Page 307 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C1.10. Diagnostic strategies—biopsy frequency

Author Database Frequency 1980- 1985- 1990- 1995- 2000- 2005- Statistical analysis Notes
Year groups 84 89 94 99 04 10
PMID
52
Schwartz SEER- P<0.001 Additional
1999 Detroit (1982) (1995) information is
10197854 (Cochran-Armitage presented in Figure 4
test for trend in of the paper.
proportion of
biopsies over time)
54
Gilliland SEER- Biopsy only 27.1% 43.7% NR Only histologically
2001 New TURP 55.6% 11.2% confirmed prostate
11176484 Mexico Prostatectomy 12.8% 38.8% cancer samples were
Other 4.5% 6.3% considered.
Percentage of (1983- (1992-
patients 84) 93)
diagnosed
through each
procedure
57
Potosky SEER- Age-adjusted 685 2600 NR Additional
1995 Medicare (1970 US (1986) (1991) information is
7530782 standard) biopsy presented in Figure 2
procedure rates of the paper.
per 100,000 men
89
Welch SEER- Age- and race- P>0.2 The authors reported
2007 Medicare adjusted biopsy (1993) (2001) (test for trend in the that “although the
17848671 rates biopsy rate over biopsy rate declined
time) over the first 3 years,
there was not a
statistically
significant trend over
the 9-year analysis
period.” Additional
information was
provided in Figure 2
of the paper.
Ordering of the studies follows Appendix Table C1.1.
NR = not reported; PMID = PubMed identification number; TURP = transurethral resection of the prostate.

C-71